Empagliflozin as a Potential Therapeutic Solution for Patients With Brugada Syndrome
NCT07146880
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Brugada Syndrome (BrS)
Interventions
DRUG:
Empagliflozin (EMPA)
Sponsor
National Taiwan University Hospital
Collaborators
[object Object]